SGS SA (SGSN)
SIX Swiss Exchange · Switzerland · prices in CHF · close of 22 Oct 2026
Key indicators
| Last close | CHF 100.90 |
|---|---|
| 52-week range | 81.36 – 101.30 |
| Return, 1 month / 3 months | +5.7% / +5.1% |
| Return, 1 year / 3 years | +18.3% / +51.0% |
| Trend | Uptrend |
| RSI (14) | 75 |
| Volatility (1 year) | 17.5% |
| Worst drawdown (1 year) | -13.6% |
| Average daily value traded | 28.07M CHF |
| Dividend yield | 3.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
SGS SA is a Swiss company based in Geneva that provides inspection, verification, testing and certification services. It helps clients check the quality, safety and compliance of their products, materials and operations. Its customers include businesses in agriculture, mining, energy, manufacturing, transport and consumer goods, along with governments and public bodies. The company carries out laboratory testing, field inspections, audits and certification work across many countries, supporting trade and helping organisations meet regulatory and industry standards.
SGS SA trades under the code SGSN on the SIX Swiss Exchange in Switzerland, with its price quoted in Swiss francs (CHF). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
SGS SA (SGSN) trades on the SIX Swiss Exchange in Switzerland. It last closed at CHF 100.90 on 22 October 2026.
Its price-based Market X-Ray is 77 out of 100 (a strong price profile), ranking 9 of 225 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 18.3% and over the last three months it rose 5.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on SIX Swiss Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 77 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 11.0% | ||
| From 52-week high | 0.0% | ||
| Momentum | 66 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 5.1% | ||
| 6-month return | 17.0% | ||
| 12-month return, skipping the last month | 11.9% | ||
| Stability (higher is calmer) | 86 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 17.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -13.6% | ||
| Liquidity | 88 · Strong | Trades actively. | |
| Average daily value traded | 28.07M CHF | ||
| Zero-volume days | 0.0% | ||
| Income | 62 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.2% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +2.2% |
|---|---|
| 1 month | +5.7% |
| 3 months | +5.1% |
| 6 months | +17.0% |
| 1 year | +18.3% |
| 3 years | +51.0% |
| 5 years | +8.4% |
Signals
| 50-day / 200-day average | 94.36 / 90.90 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.35 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Apr 2026 | CHF 3.2000 |
| 2 Apr 2025 | CHF 3.2000 |
| 28 Mar 2024 | CHF 3.2864 |
| 30 Mar 2023 | CHF 78.8840 |
| 31 Mar 2022 | CHF 78.8840 |
| 25 Mar 2021 | CHF 78.8840 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on SIX Swiss Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.